Related Experiment Video
Updated: Mar 3, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Primary Ovarian Solid Pseudopapillary Neoplasm With CTNNB1 c.98C>G (p.S33C) Point Mutation.
Kamaljeet Singh1, Nimesh Patel, Pallavi Patil
1Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island (K.S., C.P., W.D.L.) Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Rhode Island Hospital (N.P., P.P.) Program in Women's Oncology, Women & Infants Hospital (C.A.M.), Providence, Rhode Island.
This study reports a rare ovarian tumor, solid pseudopapillary neoplasm (SPN), with a specific genetic mutation (CTNNB1) also found in pancreatic SPN. This finding supports the similarity between ovarian and pancreatic SPN.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Solid pseudopapillary neoplasm (SPN) is a rare tumor typically originating in the pancreas.
- Ovary is an extrapancreatic site where SPN can rarely occur.
- Previous reports indicate limited cases of ovarian SPN, with only one confirmed CTNNB1 mutation.
Observation:
- A 49-year-old postmenopausal woman presented with a 4.5 cm right ovarian mass.
- Histologic and immunohistochemical analysis revealed features consistent with pancreatic SPN.
- The ovarian surface was intact, and the Ki-67 proliferation index was low (1%-5%).
Findings:
- DNA sequencing identified a CTNNB1 exon 3 mutation (c.98C>G, p.S33C) in the ovarian mass.
- This specific mutation is a known activating mutation previously identified in pancreatic SPN.
- This case represents the second documented instance of ovarian SPN with a confirmed CTNNB1 mutation.
Implications:
- The findings reinforce the phenotypic and genotypic similarities between primary ovarian SPN and pancreatic SPN.
- This genetic link may have implications for understanding the pathogenesis and potential therapeutic targets for ovarian SPN.
- Further research into extrapancreatic SPN is warranted to elucidate their origins and biological behavior.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation

